Symbols / CYRX Stock $15.19 -1.87% Cryoport, Inc.

Industrials • Integrated Freight & Logistics • United States • NCM
CYRX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Industrials
Industry Integrated Freight & Logistics
CEO Mr. Jerrell W. Shelton
Exch · Country NCM · United States
Market Cap 765.61M
Enterprise Value 636.74M
Income -44.66M
Sales 182.94M
FCF (ttm) 64.53M
Book/sh 8.98
Cash/sh 8.01
Employees 684
Insider 10d —
IPO Aug 22, 2005
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -24.50
PEG 62.13
P/S 4.19
P/B 1.69
P/C —
EV/EBITDA -266.75
EV/Sales 3.48
Quick Ratio 1.97
Current Ratio 2.09
Debt/Eq 46.56
LT Debt/Eq —
EPS (ttm) -0.90
EPS next Y -0.62
EPS Growth —
Revenue Growth 16.50%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-04
Earnings (prior) 2026-05-04
ROA -2.46%
ROE -8.20%
ROIC —
Gross Margin 47.19%
Oper. Margin -20.08%
Profit Margin 43.59%
Shs Outstand 50.40M
Shs Float 40.86M
Insider Own 3.87%
Instit Own 96.84%
Short Float 5.53%
Short Ratio 2.63
Short Interest 2.32M
52W High 16.73
vs 52W High -9.21%
52W Low 6.16
vs 52W Low 146.59%
Beta 1.89
Impl. Vol. 1.56%
Rel Volume 1.50
Avg Volume 661.74K
Volume 991.49K
Target (mean) $15.61
Tgt Median $15.00
Tgt Low $12.00
Tgt High $20.00
# Analysts 9
Recom Strong_buy
Prev Close $15.48
Price $15.19
Change -1.87%
About

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$15.61
Mean price target
2. Current target
$15.19
Latest analyst target
3. DCF / Fair value
$23.05
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$15.19
Low
$12.00
High
$20.00
Mean
$15.61

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-06-03 main Craig-Hallum Buy → Buy $20
2026-05-20 main Keybanc Overweight → Overweight $17
2026-05-05 main Guggenheim Buy → Buy $12
2026-05-05 main Needham Buy → Buy $15
2026-05-05 main BTIG Buy → Buy $17
2026-03-30 init Craig-Hallum — → Buy $15
2026-03-04 main Needham Buy → Buy $13
2025-11-05 main UBS Buy → Buy $13
2025-11-05 main Needham Buy → Buy $12
2025-09-18 main BTIG Buy → Buy $15
2025-08-06 up Leerink Partners Market Perform → Outperform $16
2025-08-06 up Keybanc Sector Weight → Overweight $15
2025-07-07 main BTIG Buy → Buy $10
2025-05-08 reit Needham Buy → Buy $11
2025-05-05 main Morgan Stanley Equal-Weight → Equal-Weight $7
2025-04-16 reit Needham Buy → Buy $11
2025-04-16 reit Guggenheim Buy → Buy $10
2025-04-10 reit Needham Buy → Buy $11
2025-04-01 reit Roth MKM Buy → Buy $15
2025-04-01 main UBS Buy → Buy $11
News
RSS: Latest CYRX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-08 MANDALAM RAMKUMAR Director — 23,214 $15.44 $358,452
2026-06-05 MANDALAM RAMKUMAR Director — 10,350 $0.00 $0
2026-06-04 STEFANOVICH ROBERT STEVEN Chief Financial Officer — 169,427 $16.27 $2,756,984
2026-04-21 SHELTON JERRELL WILSON Chief Executive Officer — 104,007 $1.87 $194,493
2026-04-06 SHELTON JERRELL WILSON Chief Executive Officer — 50,000 $1.87 $93,500
2026-03-23 SHELTON JERRELL WILSON Chief Executive Officer — 25,000 $1.87 $46,750
2026-03-23 SAWICKI MARK W Officer — 1,341 $8.18 $10,969
2026-03-23 STEFANOVICH ROBERT STEVEN Chief Financial Officer — 1,094 $8.18 $8,949
2026-03-23 SHELTON JERRELL WILSON Chief Executive Officer — 2,894 $8.18 $23,673
2026-03-16 ZECCHINI EDWARD J Chief Technology Officer — 2,014 $8.00 $16,112
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
176.18
+12.38%
156.77
-7.05%
168.66
-28.92%
237.28
Operating Revenue
176.18
+12.38%
156.77
-7.05%
168.66
-28.92%
237.28
Cost Of Revenue
93.12
+6.90%
87.11
-6.66%
93.33
-30.04%
133.40
Reconciled Cost Of Revenue
93.12
+6.90%
87.11
-6.66%
93.33
-30.04%
133.40
Gross Profit
83.05
+19.23%
69.66
-7.53%
75.33
-27.48%
103.87
Operating Expense
119.86
-6.01%
127.52
+0.96%
126.30
-6.98%
135.78
Research And Development
17.04
-3.78%
17.71
-1.83%
18.04
+14.74%
15.72
Selling General And Administration
102.82
-6.37%
109.81
+1.43%
108.26
-9.82%
120.06
Total Expenses
212.98
-0.77%
214.63
-2.28%
219.63
-18.41%
269.18
Operating Income
-36.81
+36.39%
-57.86
-13.53%
-50.97
-59.75%
-31.90
Total Operating Income As Reported
-36.81
+69.75%
-121.67
-21.02%
-100.54
-215.12%
-31.90
EBITDA
-2.10
+96.99%
-69.61
-36.11%
-51.15
-726.68%
-6.19
Normalized EBITDA
-11.89
+65.23%
-34.21
-91.80%
-17.83
-21.64%
-14.66
Reconciled Depreciation
27.71
-9.90%
30.76
+11.90%
27.49
+20.74%
22.77
EBIT
-29.81
+70.30%
-100.37
-27.64%
-78.63
-171.60%
-28.95
Total Unusual Items
9.80
+127.67%
-35.41
-6.29%
-33.31
-493.12%
8.47
Total Unusual Items Excluding Goodwill
9.80
+127.67%
-35.41
-6.29%
-33.31
-493.12%
8.47
Special Income Charges
0.00
+100.00%
-45.30
-3.22%
-43.89
0.00
Other Special Charges
—
-18.50
-225.85%
-5.68
—
Impairment Of Capital Assets
0.00
-100.00%
63.81
+28.73%
49.57
0.00
Net Income
78.30
+168.23%
-114.76
-15.23%
-99.59
-166.75%
-37.33
Pretax Income
-32.17
+69.17%
-104.35
-23.91%
-84.21
-139.97%
-35.09
Net Non Operating Interest Income Expense
-2.36
+40.63%
-3.98
+28.73%
-5.58
+9.15%
-6.14
Interest Expense Non Operating
2.36
-40.63%
3.98
-28.73%
5.58
-9.15%
6.14
Net Interest Income
-2.36
+40.63%
-3.98
+28.73%
-5.58
+9.15%
-6.14
Interest Expense
2.36
-40.63%
3.98
-28.73%
5.58
-9.15%
6.14
Other Income Expense
7.00
+116.46%
-42.51
-53.65%
-27.67
-1037.20%
2.95
Other Non Operating Income Expenses
-2.80
+60.55%
-7.10
-225.75%
5.65
+202.26%
-5.52
Gain On Sale Of Security
9.80
-0.98%
9.89
-6.45%
10.58
+24.82%
8.47
Tax Provision
1.80
+401.11%
0.36
+4.06%
0.34
-84.59%
2.24
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
2.06
+127.67%
-7.44
-6.29%
-7.00
-493.12%
1.78
Net Income Including Noncontrolling Interests
78.30
+168.23%
-114.76
-15.23%
-99.59
-166.75%
-37.33
Net Income From Continuing Operation Net Minority Interest
-33.97
+67.56%
-104.71
-23.83%
-84.56
-126.50%
-37.33
Net Income From Continuing And Discontinued Operation
78.30
+168.23%
-114.76
-15.23%
-99.59
-166.75%
-37.33
Net Income Continuous Operations
-33.97
+67.56%
-104.71
-23.83%
-84.56
-126.50%
-37.33
Net Income Discontinuous Operations
112.27
+1217.34%
-10.05
+33.14%
-15.03
—
Normalized Income
-41.71
+45.64%
-76.73
-31.75%
-58.24
-32.29%
-44.03
Net Income Common Stockholders
70.30
+157.27%
-122.76
-14.10%
-107.59
-137.33%
-45.33
Diluted EPS
1.40
+156.22%
-2.49
-12.67%
-2.21
-137.63%
-0.93
Basic EPS
1.40
+156.22%
-2.49
-12.67%
-2.21
-137.63%
-0.93
Basic Average Shares
50.07
+1.46%
49.35
+1.26%
48.74
-0.51%
48.99
Diluted Average Shares
50.07
+1.46%
49.35
+1.26%
48.74
-0.51%
48.99
Diluted NI Availto Com Stockholders
70.30
+157.27%
-122.76
-14.10%
-107.59
-137.33%
-45.33
Preferred Stock Dividends
8.00
+0.00%
8.00
+0.00%
8.00
+0.00%
8.00
Line Item Trend 2022-12-31
Total Assets
1,038.75
Current Assets
604.18
Cash Cash Equivalents And Short Term Investments
523.32
Cash And Cash Equivalents
36.59
Cash Equivalents
1.84
Cash Financial
34.75
Other Short Term Investments
486.73
Receivables
43.86
Accounts Receivable
43.86
Gross Accounts Receivable
45.16
Allowance For Doubtful Accounts Receivable
-1.30
Inventory
27.68
Prepaid Assets
—
Assets Held For Sale Current
—
Other Current Assets
9.32
Total Non Current Assets
434.57
Net PPE
90.48
Gross PPE
117.81
Accumulated Depreciation
-27.34
Land And Improvements
0.81
Buildings And Improvements
4.47
Machinery Furniture Equipment
23.08
Construction In Progress
15.95
Other Properties
45.57
Leases
27.08
Goodwill And Other Intangible Assets
342.13
Goodwill
151.12
Other Intangible Assets
191.01
Non Current Deferred Assets
0.95
Non Current Deferred Taxes Assets
0.95
Non Current Prepaid Assets
1.02
Other Non Current Assets
—
Total Liabilities Net Minority Interest
482.91
Current Liabilities
40.85
Payables And Accrued Expenses
34.05
Payables
28.05
Accounts Payable
28.05
Current Accrued Expenses
6.01
Pensionand Other Post Retirement Benefit Plans Current
2.45
Current Debt And Capital Lease Obligation
3.91
Current Debt
0.06
Other Current Borrowings
0.06
Current Capital Lease Obligation
3.85
Current Deferred Liabilities
0.44
Current Deferred Revenue
0.44
Other Current Liabilities
—
Total Non Current Liabilities Net Minority Interest
442.06
Liabilities Heldfor Sale Non Current
—
Long Term Debt And Capital Lease Obligation
432.00
Long Term Debt
407.06
Long Term Capital Lease Obligation
24.94
Non Current Deferred Liabilities
4.93
Non Current Deferred Taxes Liabilities
4.93
Other Non Current Liabilities
5.13
Stockholders Equity
555.84
Common Stock Equity
537.56
Capital Stock
18.32
Common Stock
0.05
Preferred Stock
18.27
Share Issued
48.33
Ordinary Shares Number
48.33
Additional Paid In Capital
1,114.90
Retained Earnings
-542.83
Gains Losses Not Affecting Retained Earnings
-34.55
Other Equity Adjustments
-34.55
Total Equity Gross Minority Interest
555.84
Total Capitalization
962.90
Working Capital
563.33
Invested Capital
944.69
Total Debt
435.91
Net Debt
370.53
Capital Lease Obligations
28.79
Net Tangible Assets
213.71
Tangible Book Value
195.44
Preferred Shares Number
0.20
Preferred Stock Equity
18.27
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.58
+47.44%
-16.32
-2056.27%
-0.76
+59.10%
-1.85
Cash Flow From Continuing Operating Activities
-8.58
+47.44%
-16.32
-2056.27%
-0.76
+59.10%
-1.85
Net Income From Continuing Operations
78.30
+168.23%
-114.76
-15.23%
-99.59
-166.75%
-37.33
Depreciation Amortization Depletion
27.71
-9.90%
30.76
+11.90%
27.49
+20.74%
22.77
Depreciation And Amortization
27.71
-9.90%
30.76
+11.90%
27.49
+20.74%
22.77
Other Non Cash Items
3.31
-43.52%
5.86
-4.50%
6.13
-50.54%
12.39
Stock Based Compensation
11.03
-44.01%
19.70
-13.61%
22.81
+13.57%
20.08
Provisionand Write Offof Assets
—
—
0.82
+251.28%
0.23
Asset Impairment Charge
0.00
-100.00%
63.81
+28.73%
49.57
0.00
Operating Gains Losses
-113.73
-713.42%
-13.98
-200.17%
-4.66
-616.41%
0.90
Gain Loss On Investment Securities
2.21
-46.63%
4.14
+6077.61%
0.07
-34.31%
0.10
Unrealized Gain Loss On Investment Securities
-1.51
-267.52%
0.90
+168.73%
-1.31
-111.47%
11.41
Gain Loss On Sale Of PPE
1.01
+163.54%
0.38
-59.75%
0.95
+19.25%
0.80
Change In Working Capital
-13.69
-59.07%
-8.61
-618.02%
-1.20
+96.26%
-32.07
Change In Receivables
-6.53
-57.32%
-4.15
-212.96%
3.67
+188.78%
-4.14
Changes In Account Receivables
-6.53
-57.32%
-4.15
-212.96%
3.67
+188.78%
-4.14
Change In Inventory
-2.19
-167.19%
3.25
+115.65%
1.51
+110.62%
-14.20
Change In Prepaid Assets
1.16
+132.41%
-3.59
-368.93%
-0.77
+53.80%
-1.66
Change In Payables And Accrued Expense
-1.55
-187.56%
1.78
+1405.08%
0.12
+101.47%
-8.05
Change In Accrued Expense
1.91
+3.08%
1.85
-35.78%
2.88
+283.81%
-1.57
Change In Payable
-3.46
-4457.89%
-0.08
+97.25%
-2.77
+57.33%
-6.48
Change In Account Payable
-3.46
-4457.89%
-0.08
+97.25%
-2.77
+57.33%
-6.48
Change In Other Working Capital
0.45
+180.04%
-0.56
+51.10%
-1.14
-20.83%
-0.94
Change In Other Current Liabilities
-5.04
+5.69%
-5.34
-16.21%
-4.59
-49.38%
-3.08
Investing Cash Flow
250.32
+41.57%
176.81
+390.54%
36.05
+160.40%
-59.68
Cash Flow From Continuing Investing Activities
250.32
+41.57%
176.81
+390.54%
36.05
+160.40%
-59.68
Net PPE Purchase And Sale
-16.44
+4.72%
-17.25
+55.51%
-38.78
-75.44%
-22.11
Purchase Of PPE
-16.44
+4.72%
-17.25
+55.51%
-38.78
-75.44%
-22.11
Capital Expenditure
-19.50
+8.29%
-21.27
+52.63%
-44.90
-85.56%
-24.20
Net Investment Purchase And Sale
59.59
-69.96%
198.40
+127.23%
87.31
+373.44%
-31.93
Purchase Of Investment
0.00
+100.00%
-50.72
-18.85%
-42.68
+73.94%
-163.79
Sale Of Investment
59.59
-76.08%
249.12
+91.65%
129.99
-1.42%
131.86
Net Business Purchase And Sale
210.24
+67269.01%
-0.31
+95.74%
-7.34
-12.01%
-6.55
Purchase Of Business
0.00
+100.00%
-0.31
+95.74%
-7.34
-12.01%
-6.55
Gain Loss On Sale Of Business
-116.95
0.00
0.00
—
Net Intangibles Purchase And Sale
-3.07
+23.60%
-4.01
+34.37%
-6.12
-192.58%
-2.09
Purchase Of Intangibles
-3.07
+23.60%
-4.01
+34.37%
-6.12
-192.58%
-2.09
Net Other Investing Changes
—
—
0.98
-67.47%
3.00
Financing Cash Flow
-21.07
+86.95%
-161.53
-578.76%
-23.80
+39.25%
-39.17
Cash Flow From Continuing Financing Activities
-21.07
+86.95%
-161.53
-578.76%
-23.80
+39.25%
-39.17
Net Issuance Payments Of Debt
-15.04
+90.85%
-164.32
-550.11%
-25.28
-674.86%
-3.26
Issuance Of Debt
—
—
0.00
0.00
Repayment Of Debt
-15.04
+90.85%
-164.32
-550.11%
-25.28
-674.86%
-3.26
Long Term Debt Issuance
—
—
0.00
0.00
Long Term Debt Payments
-15.04
+90.85%
-164.32
-550.11%
-25.28
-674.86%
-3.26
Net Long Term Debt Issuance
-15.04
+90.85%
-164.32
-550.11%
-25.28
-674.86%
-3.26
Net Common Stock Issuance
-10.01
0.00
0.00
+100.00%
-37.96
Common Stock Payments
-10.01
0.00
0.00
+100.00%
-37.96
Repurchase Of Capital Stock
-10.01
0.00
0.00
+100.00%
-37.96
Proceeds From Stock Option Exercised
3.97
+42.37%
2.79
+88.77%
1.48
-27.83%
2.05
Changes In Cash
220.67
+21338.59%
-1.04
-109.04%
11.49
+111.41%
-100.71
Effect Of Exchange Rate Changes
-15.46
-85811.11%
-0.02
+98.96%
-1.74
+3.39%
-1.80
Beginning Cash Position
45.29
-2.28%
46.35
+26.65%
36.59
-73.69%
139.10
End Cash Position
250.49
+453.10%
45.29
-2.28%
46.35
+26.65%
36.59
Free Cash Flow
-28.09
+25.29%
-37.59
+17.67%
-45.66
-75.28%
-26.05
Interest Paid Supplemental Data
1.63
-39.55%
2.69
-20.77%
3.40
-6.31%
3.63
Income Tax Paid Supplemental Data
2.19
+54.08%
1.42
-2.74%
1.46
-26.12%
1.98
Common Stock Issuance
—
—
0.00
0.00
Issuance Of Capital Stock
—
—
0.00
0.00
Net Preferred Stock Issuance
—
—
0.00
0.00
Preferred Stock Issuance
—
—
0.00
0.00
Sale Of Business
210.24
0.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category